Eli Lilly ( LLY 2.92%) has been growing its sales at a good clip over the past year. This is partly thanks to Zepbound, a ...

Weight loss drugs like Ozempic, Zepbound and Wegovy are surging in popularity. Now, a new pill from Eli Lilly has taken a ...

Weight loss medications like Wegovy and Zepbound are gaining popularity as millions turn to them for quick results and ...

Zepbound (tirzepatide) is a weekly injectable weight-loss medication. It can be purchased online or in person with a valid ...

Eli Lilly ( NYSE: LLY) has filed lawsuits against four telehealth platforms that the pharma giant alleges are selling ...

This is partly thanks to Zepbound, a weight loss medicine that's already generating more than $1 billion in quarterly sales, although it was approved only in late 2023. Zepbound's prospects still ...

Janelle Rohner claims she still followed her diet plan, noting GLP-1 weight loss drugs "don’t change your lifestyle overnight ...

As the Food and Drug Administration cracks down on compounded versions of popular weight loss drugs Wegovy (semaglutide) and Zepbound (tirzepatide), Americans who rely on these cheaper medications ...

Lilly sells tirzepatide as Mounjaro for type 2 diabetes and Zepbound for obesity. In the complaints, Lilly alleges that the telemedicine companies are marketing tirzepatide mixed with substances ...